- $16.14bn
- $18.71bn
- $8.25bn
Brief: Biotech Companies To Increase Research And Development Spend But Highlight Complexity Of Clinical Trials - Icon
Icon Plc Reports Results For The Quarter Ended In September: Earnings Summary
Icon Plc Expected To Post Earnings Of $3.28 A Share: Earnings Preview
Brief: Icon Releases Expanded End-To-End Clinical Trial Tokenisation Solution
ICON to partner with US govt agency to test COVID vaccine candidates (updated)
Icon To Partner With Us Govt Agency To Test Covid: 19 vaccine candidates
Brief: Barda Partners With Icon To Execute Next Generation Covid-19 Vaccines Clinical Trial
Brief: Value Health Solutions Wins Ruling From NC Supreme Court In Lawsuit Against PRA Health Sciences (Now Known As Icon PLC)
Icon Plc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Icon PLC Revenue For The Second Quarter Was $2,020.3 Million
Icon Plc Expected To Post Earnings Of $3.08 A Share: Earnings Preview
Investment consortium nears deal for Syneos Health -sources (updated)
Icon Plc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: ICON posts Q1 adjusted EPS of USD 2.9
Icon Plc Expected To Post Earnings Of $2.88 A Share: Earnings Preview
Contract research firms fall as Baird raises funding concerns after SVB fallout
Syneos Health eyes sale of company as contract backlog shrinks-sources
Syneos Health eyes sale of company as contract backlog shrinks-sources
Icon Plc Reports Results For The Quarter Ended In December: Earnings Summary